VERU

VERU

USD

Veru Inc. Common Stock

$2.650+0.070 (2.713%)

即時價格

Healthcare
生物科技
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$2.580

最高

$2.650

最低

$2.580

交易量

0.18M

公司基本面

市值

42.5M

行業

生物科技

國家

United States

交易統計

平均交易量

0.18M

交易所

NCM

貨幣

USD

52週範圍

最低 $2.42當前 $2.650最高 $14.2

AI分析報告

最後更新: 2025年11月10日
由AI生成數據來源: Yahoo Finance, Bloomberg, SEC

VERU Stock Analysis: Veru Inc. Navigates Volatility Amid Fundamental Challenges

Market Snapshot

Current Price: $2.61 (as of 2025-11-10) 52-Week Range: $2.42 - $14.20 Market Cap: $41.89M | P/E Ratio: -9.00 Recent Volatility: Sharp decline from $4.43 (Oct 20) to $2.61, with erratic volume patterns


Recent Performance: Turbulent Descent

Veru’s stock has been in a clear downtrend since mid-October, shedding 41% from its October peak. Key observations:

  • Public Offering Impact: The $25M offering on Oct 30 likely triggered selling pressure, with shares dropping 12% the following day.
  • Volume Anomalies: Unusually high trading volume on Oct 30 ($765,700) and Nov 3 ($489,500) suggests panic selling or institutional exits.
  • Support Zone: Recent closes near $2.52-$2.58 align with its 52-week low, indicating this range may act as temporary support.

Technical Signals: Mixed Messages

  • Bullish DMI: +DI (15.4) > -DI (14.1) with ADX at 19.0 implies a weak uptrend could form if buyers step in.
  • Volume Surge: 1.9x average volume on Nov 10 hints at renewed interest, but this could reflect short-term positioning rather than sustainable demand.
  • MACD Death Cross: Bearish momentum confirmed as MACD (0.0119) fell below signal line (0.0162) despite AI’s upward projections.

Fundamentals: Value Trap or Hidden Potential?

  • Contradictory Valuation: While the P/E (-9.00) appears broken due to negative earnings, the recommendation claims it’s “0.4x industry average” (likely referencing EBITDA multiples or forward estimates). Proceed with skepticism.
  • **High-Risk

相關新聞

GlobeNewswire

Veru to Present Two Abstracts at ObesityWeek 2025

MIAMI, FL, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory

查看更多
Veru to Present Two Abstracts at ObesityWeek 2025
GlobeNewswire

Veru Announces Pricing of $25 Million Public Offering

MIAMI, FL, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory

查看更多
Veru Announces Pricing of $25 Million Public Offering

AI預測Beta

AI推薦

看漲

更新於: 2025年11月10日 下午02:42

看跌中立看漲

58.4% 信心度

風險與交易

風險級別3/5
中等風險
適合
價值
交易指南

入場點

$2.52

獲利了結

$2.61

止損

$2.30

關鍵因素

PDI 15.4 在 MDI 14.1 上方,ADX 19.0,表明看漲趨勢
交易量是平均值 (3,174) 的 1.9 倍,表明市場參與度增加
MACD 0.0119 在信號線 0.0162 下方,表示看跌交叉

保持更新

設定價格提醒,獲取AI分析更新和即時市場新聞。